 | • レポートコード：QYR2104Z3221 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、153ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、インターベンショナルオンコロジーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アブレーション装置、塞栓装置、サポート装置）、用途別市場規模（肝臓がん、肺がん、腎臓がん、骨がん、乳がん、前立腺がん、膵臓がん）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・インターベンショナルオンコロジーの市場動向 ・企業の競争状況、市場シェア ・インターベンショナルオンコロジーの種類別市場規模（アブレーション装置、塞栓装置、サポート装置） ・インターベンショナルオンコロジーの用途別市場規模（肝臓がん、肺がん、腎臓がん、骨がん、乳がん、前立腺がん、膵臓がん） ・インターベンショナルオンコロジーの北米市場規模2016-2027（アメリカ、カナダ） ・インターベンショナルオンコロジーのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・インターベンショナルオンコロジーのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・インターベンショナルオンコロジーの中南米市場規模2016-2027（メキシコ、ブラジル） ・インターベンショナルオンコロジーの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Boston Scientific、BTG、Medtronic、Merit Medical、Terumo、Accuray、Alpinion Medical Systems、Angiodynamics、Atricure、Baylis Medical、Bovie Medical、Brainlab、Bsd Medical、C. R. Bard、C2 Therapeutics、Cardiofocus、Cook Medical、Eckert And Ziegler Bebig、Edap Tms、Elekta、Galil Medical、Healthtronics、Insightec、Medwaves、Mermaid Medical、Microsulis Medical、Monteris Medical） ・結論 |
Interventional oncology is a subspecialty field of interventional radiology that deals with the diagnosis and treatment of cancerand cancer-related problems using targeted minimally invasive procedures performed under image guidance.
Interventional oncology has developed to a separate pillar of modern oncology and it employs X-ray, ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI) to help guide miniaturized instruments (e.g. biopsy needles, ablation electrodes, intravascular catheters) to allow targeted and precise treatment of solid tumours located in various organs of the human body, including but not limited to the liver, kidneys, lungs, and bones. Interventional oncology treatments are routinely carried out by interventional radiologists in appropriate settings and facilities.
Market Analysis and Insights: Global Interventional Oncology Market
The global Interventional Oncology market size is projected to reach US$ 2185.3 million by 2026, from US$ 1671.8 million in 2019, at a CAGR of 3.9% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Interventional Oncology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Interventional Oncology market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Interventional Oncology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Interventional Oncology market.
Global Interventional Oncology Scope and Market Size
Interventional Oncology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Interventional Oncology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Ablation Devices
Embolization Devices
Support Devices
Segment by Application
Liver Cancer
Lung Cancer
Kidney Cancer
Bone Cancer
Breast Cancer
Prostate Cancer
Pancreatic Cancer
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Boston Scientific
BTG
Medtronic
Merit Medical
Terumo
Accuray
Alpinion Medical Systems
Angiodynamics
Atricure
Merit Medical
Terumo
Brainlab
Bsd Medical
C. R. Bard
C2 Therapeutics
Cardiofocus
Cook Medical
Eckert And Ziegler Bebig
Edap Tms
Elekta
Galil Medical
Healthtronics
Insightec
Medwaves
Mermaid Medical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Interventional Oncology Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Ablation Devices
1.2.3 Embolization Devices
1.2.4 Support Devices
1.3 Market by Application
1.3.1 Global Interventional Oncology Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Liver Cancer
1.3.3 Lung Cancer
1.3.4 Kidney Cancer
1.3.5 Bone Cancer
1.3.6 Breast Cancer
1.3.7 Prostate Cancer
1.3.8 Pancreatic Cancer
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Interventional Oncology Market Perspective (2016-2027)
2.2 Interventional Oncology Growth Trends by Regions
2.2.1 Interventional Oncology Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Interventional Oncology Historic Market Share by Regions (2016-2021)
2.2.3 Interventional Oncology Forecasted Market Size by Regions (2022-2027)
2.3 Interventional Oncology Industry Dynamic
2.3.1 Interventional Oncology Market Trends
2.3.2 Interventional Oncology Market Drivers
2.3.3 Interventional Oncology Market Challenges
2.3.4 Interventional Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Interventional Oncology Players by Revenue
3.1.1 Global Top Interventional Oncology Players by Revenue (2016-2021)
3.1.2 Global Interventional Oncology Revenue Market Share by Players (2016-2021)
3.2 Global Interventional Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Interventional Oncology Revenue
3.4 Global Interventional Oncology Market Concentration Ratio
3.4.1 Global Interventional Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Interventional Oncology Revenue in 2020
3.5 Interventional Oncology Key Players Head office and Area Served
3.6 Key Players Interventional Oncology Product Solution and Service
3.7 Date of Enter into Interventional Oncology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Interventional Oncology Breakdown Data by Type
4.1 Global Interventional Oncology Historic Market Size by Type (2016-2021)
4.2 Global Interventional Oncology Forecasted Market Size by Type (2022-2027)
5 Interventional Oncology Breakdown Data by Application
5.1 Global Interventional Oncology Historic Market Size by Application (2016-2021)
5.2 Global Interventional Oncology Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Interventional Oncology Market Size (2016-2027)
6.2 North America Interventional Oncology Market Size by Type
6.2.1 North America Interventional Oncology Market Size by Type (2016-2021)
6.2.2 North America Interventional Oncology Market Size by Type (2022-2027)
6.2.3 North America Interventional Oncology Market Size by Type (2016-2027)
6.3 North America Interventional Oncology Market Size by Application
6.3.1 North America Interventional Oncology Market Size by Application (2016-2021)
6.3.2 North America Interventional Oncology Market Size by Application (2022-2027)
6.3.3 North America Interventional Oncology Market Size by Application (2016-2027)
6.4 North America Interventional Oncology Market Size by Country
6.4.1 North America Interventional Oncology Market Size by Country (2016-2021)
6.4.2 North America Interventional Oncology Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Interventional Oncology Market Size (2016-2027)
7.2 Europe Interventional Oncology Market Size by Type
7.2.1 Europe Interventional Oncology Market Size by Type (2016-2021)
7.2.2 Europe Interventional Oncology Market Size by Type (2022-2027)
7.2.3 Europe Interventional Oncology Market Size by Type (2016-2027)
7.3 Europe Interventional Oncology Market Size by Application
7.3.1 Europe Interventional Oncology Market Size by Application (2016-2021)
7.3.2 Europe Interventional Oncology Market Size by Application (2022-2027)
7.3.3 Europe Interventional Oncology Market Size by Application (2016-2027)
7.4 Europe Interventional Oncology Market Size by Country
7.4.1 Europe Interventional Oncology Market Size by Country (2016-2021)
7.4.2 Europe Interventional Oncology Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Interventional Oncology Market Size (2016-2027)
8.2 Asia-Pacific Interventional Oncology Market Size by Type
8.2.1 Asia-Pacific Interventional Oncology Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Interventional Oncology Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Interventional Oncology Market Size by Type (2016-2027)
8.3 Asia-Pacific Interventional Oncology Market Size by Application
8.3.1 Asia-Pacific Interventional Oncology Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Interventional Oncology Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Interventional Oncology Market Size by Application (2016-2027)
8.4 Asia-Pacific Interventional Oncology Market Size by Region
8.4.1 Asia-Pacific Interventional Oncology Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Interventional Oncology Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Interventional Oncology Market Size (2016-2027)
9.2 Latin America Interventional Oncology Market Size by Type
9.2.1 Latin America Interventional Oncology Market Size by Type (2016-2021)
9.2.2 Latin America Interventional Oncology Market Size by Type (2022-2027)
9.2.3 Latin America Interventional Oncology Market Size by Type (2016-2027)
9.3 Latin America Interventional Oncology Market Size by Application
9.3.1 Latin America Interventional Oncology Market Size by Application (2016-2021)
9.3.2 Latin America Interventional Oncology Market Size by Application (2022-2027)
9.3.3 Latin America Interventional Oncology Market Size by Application (2016-2027)
9.4 Latin America Interventional Oncology Market Size by Country
9.4.1 Latin America Interventional Oncology Market Size by Country (2016-2021)
9.4.2 Latin America Interventional Oncology Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Interventional Oncology Market Size (2016-2027)
10.2 Middle East & Africa Interventional Oncology Market Size by Type
10.2.1 Middle East & Africa Interventional Oncology Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Interventional Oncology Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Interventional Oncology Market Size by Type (2016-2027)
10.3 Middle East & Africa Interventional Oncology Market Size by Application
10.3.1 Middle East & Africa Interventional Oncology Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Interventional Oncology Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Interventional Oncology Market Size by Application (2016-2027)
10.4 Middle East & Africa Interventional Oncology Market Size by Country
10.4.1 Middle East & Africa Interventional Oncology Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Interventional Oncology Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Boston Scientific
11.1.1 Boston Scientific Company Details
11.1.2 Boston Scientific Business Overview
11.1.3 Boston Scientific Interventional Oncology Introduction
11.1.4 Boston Scientific Revenue in Interventional Oncology Business (2016-2021)
11.1.5 Boston Scientific Recent Development
11.2 BTG
11.2.1 BTG Company Details
11.2.2 BTG Business Overview
11.2.3 BTG Interventional Oncology Introduction
11.2.4 BTG Revenue in Interventional Oncology Business (2016-2021)
11.2.5 BTG Recent Development
11.3 Medtronic
11.3.1 Medtronic Company Details
11.3.2 Medtronic Business Overview
11.3.3 Medtronic Interventional Oncology Introduction
11.3.4 Medtronic Revenue in Interventional Oncology Business (2016-2021)
11.3.5 Medtronic Recent Development
11.4 Merit Medical
11.4.1 Merit Medical Company Details
11.4.2 Merit Medical Business Overview
11.4.3 Merit Medical Interventional Oncology Introduction
11.4.4 Merit Medical Revenue in Interventional Oncology Business (2016-2021)
11.4.5 Merit Medical Recent Development
11.5 Terumo
11.5.1 Terumo Company Details
11.5.2 Terumo Business Overview
11.5.3 Terumo Interventional Oncology Introduction
11.5.4 Terumo Revenue in Interventional Oncology Business (2016-2021)
11.5.5 Terumo Recent Development
11.6 Accuray
11.6.1 Accuray Company Details
11.6.2 Accuray Business Overview
11.6.3 Accuray Interventional Oncology Introduction
11.6.4 Accuray Revenue in Interventional Oncology Business (2016-2021)
11.6.5 Accuray Recent Development
11.7 Alpinion Medical Systems
11.7.1 Alpinion Medical Systems Company Details
11.7.2 Alpinion Medical Systems Business Overview
11.7.3 Alpinion Medical Systems Interventional Oncology Introduction
11.7.4 Alpinion Medical Systems Revenue in Interventional Oncology Business (2016-2021)
11.7.5 Alpinion Medical Systems Recent Development
11.8 Angiodynamics
11.8.1 Angiodynamics Company Details
11.8.2 Angiodynamics Business Overview
11.8.3 Angiodynamics Interventional Oncology Introduction
11.8.4 Angiodynamics Revenue in Interventional Oncology Business (2016-2021)
11.8.5 Angiodynamics Recent Development
11.9 Atricure
11.9.1 Atricure Company Details
11.9.2 Atricure Business Overview
11.9.3 Atricure Interventional Oncology Introduction
11.9.4 Atricure Revenue in Interventional Oncology Business (2016-2021)
11.9.5 Atricure Recent Development
11.10 Baylis Medical
11.10.1 Baylis Medical Company Details
11.10.2 Baylis Medical Business Overview
11.10.3 Baylis Medical Interventional Oncology Introduction
11.10.4 Baylis Medical Revenue in Interventional Oncology Business (2016-2021)
11.10.5 Baylis Medical Recent Development
11.11 Bovie Medical
11.11.1 Bovie Medical Company Details
11.11.2 Bovie Medical Business Overview
11.11.3 Bovie Medical Interventional Oncology Introduction
11.11.4 Bovie Medical Revenue in Interventional Oncology Business (2016-2021)
11.11.5 Bovie Medical Recent Development
11.12 Brainlab
11.12.1 Brainlab Company Details
11.12.2 Brainlab Business Overview
11.12.3 Brainlab Interventional Oncology Introduction
11.12.4 Brainlab Revenue in Interventional Oncology Business (2016-2021)
11.12.5 Brainlab Recent Development
11.13 Bsd Medical
11.13.1 Bsd Medical Company Details
11.13.2 Bsd Medical Business Overview
11.13.3 Bsd Medical Interventional Oncology Introduction
11.13.4 Bsd Medical Revenue in Interventional Oncology Business (2016-2021)
11.13.5 Bsd Medical Recent Development
11.14 C. R. Bard
11.14.1 C. R. Bard Company Details
11.14.2 C. R. Bard Business Overview
11.14.3 C. R. Bard Interventional Oncology Introduction
11.14.4 C. R. Bard Revenue in Interventional Oncology Business (2016-2021)
11.14.5 C. R. Bard Recent Development
11.15 C2 Therapeutics
11.15.1 C2 Therapeutics Company Details
11.15.2 C2 Therapeutics Business Overview
11.15.3 C2 Therapeutics Interventional Oncology Introduction
11.15.4 C2 Therapeutics Revenue in Interventional Oncology Business (2016-2021)
11.15.5 C2 Therapeutics Recent Development
11.16 Cardiofocus
11.16.1 Cardiofocus Company Details
11.16.2 Cardiofocus Business Overview
11.16.3 Cardiofocus Interventional Oncology Introduction
11.16.4 Cardiofocus Revenue in Interventional Oncology Business (2016-2021)
11.16.5 Cardiofocus Recent Development
11.17 Cook Medical
11.17.1 Cook Medical Company Details
11.17.2 Cook Medical Business Overview
11.17.3 Cook Medical Interventional Oncology Introduction
11.17.4 Cook Medical Revenue in Interventional Oncology Business (2016-2021)
11.17.5 Cook Medical Recent Development
11.18 Eckert And Ziegler Bebig
11.18.1 Eckert And Ziegler Bebig Company Details
11.18.2 Eckert And Ziegler Bebig Business Overview
11.18.3 Eckert And Ziegler Bebig Interventional Oncology Introduction
11.18.4 Eckert And Ziegler Bebig Revenue in Interventional Oncology Business (2016-2021)
11.18.5 Eckert And Ziegler Bebig Recent Development
11.18 Edap Tms
11.25.1 Edap Tms Company Details
11.25.2 Edap Tms Business Overview
11.25.3 Edap Tms Interventional Oncology Introduction
11.25.4 Edap Tms Revenue in Interventional Oncology Business (2016-2021)
11.25.5 Edap Tms Recent Development
11.20 Elekta
11.20.1 Elekta Company Details
11.20.2 Elekta Business Overview
11.20.3 Elekta Interventional Oncology Introduction
11.20.4 Elekta Revenue in Interventional Oncology Business (2016-2021)
11.20.5 Elekta Recent Development
11.21 Galil Medical
11.21.1 Galil Medical Company Details
11.21.2 Galil Medical Business Overview
11.21.3 Galil Medical Interventional Oncology Introduction
11.21.4 Galil Medical Revenue in Interventional Oncology Business (2016-2021)
11.21.5 Galil Medical Recent Development
11.22 Healthtronics
11.22.1 Healthtronics Company Details
11.22.2 Healthtronics Business Overview
11.22.3 Healthtronics Interventional Oncology Introduction
11.22.4 Healthtronics Revenue in Interventional Oncology Business (2016-2021)
11.22.5 Healthtronics Recent Development
11.23 Insightec
11.23.1 Insightec Company Details
11.23.2 Insightec Business Overview
11.23.3 Insightec Interventional Oncology Introduction
11.23.4 Insightec Revenue in Interventional Oncology Business (2016-2021)
11.23.5 Insightec Recent Development
11.24 Medwaves
11.24.1 Medwaves Company Details
11.24.2 Medwaves Business Overview
11.24.3 Medwaves Interventional Oncology Introduction
11.24.4 Medwaves Revenue in Interventional Oncology Business (2016-2021)
11.24.5 Medwaves Recent Development
11.25 Mermaid Medical
11.25.1 Mermaid Medical Company Details
11.25.2 Mermaid Medical Business Overview
11.25.3 Mermaid Medical Interventional Oncology Introduction
11.25.4 Mermaid Medical Revenue in Interventional Oncology Business (2016-2021)
11.25.5 Mermaid Medical Recent Development
11.26 Microsulis Medical
11.26.1 Microsulis Medical Company Details
11.26.2 Microsulis Medical Business Overview
11.26.3 Microsulis Medical Interventional Oncology Introduction
11.26.4 Microsulis Medical Revenue in Interventional Oncology Business (2016-2021)
11.26.5 Microsulis Medical Recent Development
11.27 Monteris Medical
11.27.1 Monteris Medical Company Details
11.27.2 Monteris Medical Business Overview
11.27.3 Monteris Medical Interventional Oncology Introduction
11.27.4 Monteris Medical Revenue in Interventional Oncology Business (2016-2021)
11.27.5 Monteris Medical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Interventional Oncology Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Ablation Devices
Table 3. Key Players of Embolization Devices
Table 4. Key Players of Support Devices
Table 5. Global Interventional Oncology Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Interventional Oncology Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Interventional Oncology Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Interventional Oncology Market Share by Regions (2016-2021)
Table 9. Global Interventional Oncology Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Interventional Oncology Market Share by Regions (2022-2027)
Table 11. Interventional Oncology Market Trends
Table 12. Interventional Oncology Market Drivers
Table 13. Interventional Oncology Market Challenges
Table 14. Interventional Oncology Market Restraints
Table 15. Global Interventional Oncology Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Interventional Oncology Market Share by Players (2016-2021)
Table 17. Global Top Interventional Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Interventional Oncology as of 2020)
Table 18. Ranking of Global Top Interventional Oncology Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Interventional Oncology Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Interventional Oncology Product Solution and Service
Table 22. Date of Enter into Interventional Oncology Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Interventional Oncology Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Interventional Oncology Revenue Market Share by Type (2016-2021)
Table 26. Global Interventional Oncology Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Interventional Oncology Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Interventional Oncology Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Interventional Oncology Revenue Market Share by Application (2016-2021)
Table 30. Global Interventional Oncology Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Interventional Oncology Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Interventional Oncology Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Interventional Oncology Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Interventional Oncology Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Interventional Oncology Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Interventional Oncology Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Interventional Oncology Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Interventional Oncology Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Interventional Oncology Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Interventional Oncology Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Interventional Oncology Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Interventional Oncology Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Interventional Oncology Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Interventional Oncology Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Interventional Oncology Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Interventional Oncology Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Interventional Oncology Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Interventional Oncology Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Interventional Oncology Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Interventional Oncology Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Interventional Oncology Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Interventional Oncology Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Interventional Oncology Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Interventional Oncology Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Interventional Oncology Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Interventional Oncology Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Interventional Oncology Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Interventional Oncology Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Interventional Oncology Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Interventional Oncology Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Interventional Oncology Market Size by Country (2022-2027) & (US$ Million)
Table 62. Boston Scientific Company Details
Table 63. Boston Scientific Business Overview
Table 64. Boston Scientific Interventional Oncology Product
Table 65. Boston Scientific Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
Table 66. Boston Scientific Recent Development
Table 67. BTG Company Details
Table 68. BTG Business Overview
Table 69. BTG Interventional Oncology Product
Table 70. BTG Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
Table 71. BTG Recent Development
Table 72. Medtronic Company Details
Table 73. Medtronic Business Overview
Table 74. Medtronic Interventional Oncology Product
Table 75. Medtronic Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
Table 76. Medtronic Recent Development
Table 77. Merit Medical Company Details
Table 78. Merit Medical Business Overview
Table 79. Merit Medical Interventional Oncology Product
Table 80. Merit Medical Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
Table 81. Merit Medical Recent Development
Table 82. Terumo Company Details
Table 83. Terumo Business Overview
Table 84. Terumo Interventional Oncology Product
Table 85. Terumo Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
Table 86. Terumo Recent Development
Table 87. Accuray Company Details
Table 88. Accuray Business Overview
Table 89. Accuray Interventional Oncology Product
Table 90. Accuray Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
Table 91. Accuray Recent Development
Table 92. Alpinion Medical Systems Company Details
Table 93. Alpinion Medical Systems Business Overview
Table 94. Alpinion Medical Systems Interventional Oncology Product
Table 95. Alpinion Medical Systems Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
Table 96. Alpinion Medical Systems Recent Development
Table 97. Angiodynamics Company Details
Table 98. Angiodynamics Business Overview
Table 99. Angiodynamics Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
Table 100. Angiodynamics Recent Development
Table 101. Atricure Company Details
Table 102. Atricure Business Overview
Table 103. Atricure Interventional Oncology Product
Table 104. Atricure Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
Table 105. Atricure Recent Development
Table 106. Baylis Medical Company Details
Table 107. Baylis Medical Business Overview
Table 108. Baylis Medical Interventional Oncology Product
Table 109. Baylis Medical Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
Table 110. Baylis Medical Recent Development
Table 111. Bovie Medical Company Details
Table 112. Bovie Medical Business Overview
Table 113. Bovie Medical Interventional Oncology Product
Table 114. Bovie Medical Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
Table 115. Bovie Medical Recent Development
Table 116. Brainlab Company Details
Table 117. Brainlab Business Overview
Table 118. Brainlab Interventional Oncology Product
Table 119. Brainlab Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
Table 120. Brainlab Recent Development
Table 121. Bsd Medical Company Details
Table 122. Bsd Medical Business Overview
Table 123. Bsd Medical Interventional Oncology Product
Table 124. Bsd Medical Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
Table 125. Bsd Medical Recent Development
Table 126. C. R. Bard Company Details
Table 127. C. R. Bard Business Overview
Table 128. C. R. Bard Interventional Oncology Product
Table 129. C. R. Bard Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
Table 130. C. R. Bard Recent Development
Table 131. C2 Therapeutics Company Details
Table 132. C2 Therapeutics Business Overview
Table 133. C2 Therapeutics Interventional Oncology Product
Table 134. C2 Therapeutics Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
Table 135. C2 Therapeutics Recent Development
Table 136. Cardiofocus Company Details
Table 137. Cardiofocus Business Overview
Table 138. Cardiofocus Interventional Oncology Product
Table 139. Cardiofocus Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
Table 140. Cardiofocus Recent Development
Table 141. Cook Medical Company Details
Table 142. Cook Medical Business Overview
Table 143. Cook Medical Interventional Oncology Product
Table 144. Cook Medical Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
Table 145. Cook Medical Recent Development
Table 146. Eckert And Ziegler Bebig Company Details
Table 147. Eckert And Ziegler Bebig Business Overview
Table 148. Eckert And Ziegler Bebig Interventional Oncology Product
Table 149. Eckert And Ziegler Bebig Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
Table 150. Eckert And Ziegler Bebig Recent Development
Table 151. Edap Tms Company Details
Table 152. Edap Tms Business Overview
Table 153. Edap Tms Interventional Oncology Product
Table 154. Edap Tms Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
Table 155. Edap Tms Recent Development
Table 156. Elekta Company Details
Table 157. Elekta Business Overview
Table 158. Elekta Interventional Oncology Product
Table 159. Elekta Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
Table 160. Elekta Recent Development
Table 161. Galil Medical Company Details
Table 162. Galil Medical Business Overview
Table 163. Galil Medical Interventional Oncology Product
Table 164. Galil Medical Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
Table 165. Galil Medical Recent Development
Table 166. Healthtronics Company Details
Table 167. Healthtronics Business Overview
Table 168. Healthtronics Interventional Oncology Product
Table 169. Healthtronics Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
Table 170. Healthtronics Recent Development
Table 171. Insightec Company Details
Table 172. Insightec Business Overview
Table 173. Insightec Interventional Oncology Product
Table 174. Insightec Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
Table 175. Insightec Recent Development
Table 176. Medwaves Company Details
Table 177. Medwaves Business Overview
Table 178. Medwaves Interventional OncologyProduct
Table 179. Medwaves Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
Table 180. Medwaves Recent Development
Table 181. Mermaid Medical Company Details
Table 182. Mermaid Medical Business Overview
Table 183. Mermaid Medical Interventional Oncology Product
Table 184. Mermaid Medical Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
Table 185. Mermaid Medical Recent Development
Table 186. Microsulis Medical Company Details
Table 187. Microsulis Medical Business Overview
Table 188. Microsulis Medical Interventional Oncology Product
Table 189. Microsulis Medical Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
Table 190. Microsulis Medical Recent Development
Table 191. Monteris Medical Company Details
Table 192. Monteris Medical Business Overview
Table 193. Monteris Medical Interventional Oncology Product
Table 194. Monteris Medical Revenue in Interventional Oncology Business (2016-2021) & (US$ Million)
Table 195. Monteris Medical Recent Development
Table 196. Research Programs/Design for This Report
Table 197. Key Data Information from Secondary Sources
Table 198. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Interventional Oncology Market Share by Type: 2020 VS 2027
Figure 2. Ablation Devices Features
Figure 3. Embolization Devices Features
Figure 4. Support Devices Features
Figure 5. Global Interventional Oncology Market Share by Application: 2020 VS 2027
Figure 6. Liver Cancer Case Studies
Figure 7. Lung Cancer Case Studies
Figure 8. Kidney Cancer Case Studies
Figure 9. Bone Cancer Case Studies
Figure 10. Breast Cancer Case Studies
Figure 11. Prostate Cancer Case Studies
Figure 12. Pancreatic Cancer Case Studies
Figure 13. Interventional Oncology Report Years Considered
Figure 14. Global Interventional Oncology Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Interventional Oncology Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Interventional Oncology Market Share by Regions: 2020 VS 2027
Figure 17. Global Interventional Oncology Market Share by Regions (2022-2027)
Figure 18. Global Interventional Oncology Market Share by Players in 2020
Figure 19. Global Top Interventional Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Interventional Oncology as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Interventional Oncology Revenue in 2020
Figure 21. Global Interventional Oncology Revenue Market Share by Type (2016-2021)
Figure 22. Global Interventional Oncology Revenue Market Share by Type (2022-2027)
Figure 23. North America Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Interventional Oncology Market Share by Type (2016-2027)
Figure 25. North America Interventional Oncology Market Share by Application (2016-2027)
Figure 26. North America Interventional Oncology Market Share by Country (2016-2027)
Figure 27. United States Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Interventional Oncology Market Share by Type (2016-2027)
Figure 31. Europe Interventional Oncology Market Share by Application (2016-2027)
Figure 32. Europe Interventional Oncology Market Share by Country (2016-2027)
Figure 33. Germany Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Interventional Oncology Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Interventional Oncology Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Interventional Oncology Market Share by Region (2016-2027)
Figure 43. China Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Interventional Oncology Market Share by Type (2016-2027)
Figure 51. Latin America Interventional Oncology Market Share by Application (2016-2027)
Figure 52. Latin America Interventional Oncology Market Share by Country (2016-2027)
Figure 53. Mexico Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Interventional Oncology Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Interventional Oncology Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Interventional Oncology Market Share by Country (2016-2027)
Figure 59. Turkey Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Interventional Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Boston Scientific Revenue Growth Rate in Interventional Oncology Business (2016-2021)
Figure 63. BTG Revenue Growth Rate in Interventional Oncology Business (2016-2021)
Figure 64. Medtronic Revenue Growth Rate in Interventional Oncology Business (2016-2021)
Figure 65. Merit Medical Revenue Growth Rate in Interventional Oncology Business (2016-2021)
Figure 66. Terumo Revenue Growth Rate in Interventional Oncology Business (2016-2021)
Figure 67. Accuray Revenue Growth Rate in Interventional Oncology Business (2016-2021)
Figure 68. Alpinion Medical Systems Revenue Growth Rate in Interventional Oncology Business (2016-2021)
Figure 69. Angiodynamics Revenue Growth Rate in Interventional Oncology Business (2016-2021)
Figure 70. Atricure Revenue Growth Rate in Interventional Oncology Business (2016-2021)
Figure 71. Baylis Medical Revenue Growth Rate in Interventional Oncology Business (2016-2021)
Figure 72. Bovie Medical Revenue Growth Rate in Interventional Oncology Business (2016-2021)
Figure 73. Brainlab Revenue Growth Rate in Interventional Oncology Business (2016-2021)
Figure 74. Bsd Medical Revenue Growth Rate in Interventional Oncology Business (2016-2021)
Figure 75. C. R. Bard Revenue Growth Rate in Interventional Oncology Business (2016-2021)
Figure 76. C2 Therapeutics Revenue Growth Rate in Interventional Oncology Business (2016-2021)
Figure 77. Cardiofocus Revenue Growth Rate in Interventional Oncology Business (2016-2021)
Figure 78. Cook Medical Revenue Growth Rate in Interventional Oncology Business (2016-2021)
Figure 79. Eckert And Ziegler Bebig Revenue Growth Rate in Interventional Oncology Business (2016-2021)
Figure 80. Edap Tms Revenue Growth Rate in Interventional Oncology Business (2016-2021)
Figure 81. Elekta Revenue Growth Rate in Interventional Oncology Business (2016-2021)
Figure 82. Galil Medical Revenue Growth Rate in Interventional Oncology Business (2016-2021)
Figure 83. Healthtronics Revenue Growth Rate in Interventional Oncology Business (2016-2021)
Figure 84. Insightec Revenue Growth Rate in Interventional Oncology Business (2016-2021)
Figure 85. Medwaves Revenue Growth Rate in Interventional Oncology Business (2016-2021)
Figure 86. Mermaid Medical Revenue Growth Rate in Interventional Oncology Business (2016-2021)
Figure 87. Microsulis Medical Revenue Growth Rate in Interventional Oncology Business (2016-2021)
Figure 88. Monteris Medical Revenue Growth Rate in Interventional Oncology Business (2016-2021)
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
世界の膵臓がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pancreatic Cancer Treatment Market The global Pancreatic Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…- 世界の膵臓がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pancreatic Cancer Treatment Market The global Pancreatic Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…
- 世界の膵臓がん治療市場規模・現状・予測（2021年-2027年） Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity …
- 世界の膵臓がん治療薬市場規模・現状・予測（2021年-2027年） Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity …
- 世界の膵臓がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pancreatic Cancer Treatment Drugs Market The global Pancreatic Cancer Treatment Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high da…